EU MDR 2017/745: Optimizing Clinical Evaluation Reports within the Medical Device Lifecycle
August 7, 2018 - Online ON CAXtalks
fbonilla@xtalks.com
Phone:4169776555
In this webinar, NAMSA’s Manager of Medical Writing and Regulatory Services (EMEA), will examine the requirements listed in the MDR and MEDDEV 2.7/1 Rev 4, and discuss why device manufacturers shall not consider the CER a mandatory document for NBs or authorities, but rather as a crucial tool for a smooth transition for MDR and beyond.
This website uses cookies to ensure you get the best experience on our website. Learn more